Trials / Not Yet Recruiting
Not Yet RecruitingNCT07044388
Coping With Asthma Throughout Life Management Program
Coping With Asthma Throughout Life Management: CALM Program for African American Adult Patients With Asthma
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if the Coping with Asthma through Life Management (CALM) intervention, designed to help Black adult with asthma cope with stress, is feasible and acceptable.
Detailed description
Asthma medication nonadherence is a major contributor to asthma morbidity and mortality in Black adults. Black adults with asthma reported that increased psychosocial stress (e.g., perceived discrimination, job stress, caregiver burden), health-related stress (e.g., concern about asthma control), and economic stress (e.g., economic strain) were barriers to asthma medication adherence and control. The study's hypothesis is that CALM, targeting multiple stressors specifically faced by Black adults with asthma, will be feasibly implemented in a health system, will be acceptable to program participants, and will be a potentially effective intervention to improve asthma medication adherence and asthma control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Coping with asthma through life management program | Participants will complete surveys, learn stress coping strategies, receive asthma education information, and obtain access local community financial resources. |
| BEHAVIORAL | Waitlist Control (CALM) | Participants in this group will complete surveys but will not receive the CALM intervention. Upon completing the study after 12 weeks they will be able to complete the program if they would like the resources/materials to learn healthy stress coping strategies, asthma health education, and access to financial resources. |
Timeline
- Start date
- 2026-06-15
- Primary completion
- 2026-07-30
- Completion
- 2026-09-30
- First posted
- 2025-07-01
- Last updated
- 2026-03-20
Source: ClinicalTrials.gov record NCT07044388. Inclusion in this directory is not an endorsement.